149 related articles for article (PubMed ID: 30391539)
21. QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers.
Brener O; Dunkelmann T; Gremer L; van Groen T; Mirecka EA; Kadish I; Willuweit A; Kutzsche J; Jürgens D; Rudolph S; Tusche M; Bongen P; Pietruszka J; Oesterhelt F; Langen KJ; Demuth HU; Janssen A; Hoyer W; Funke SA; Nagel-Steger L; Willbold D
Sci Rep; 2015 Sep; 5():13222. PubMed ID: 26394756
[TBL] [Abstract][Full Text] [Related]
22. Oral treatment with the d-enantiomeric peptide D3 improves the pathology and behavior of Alzheimer's Disease transgenic mice.
Aileen Funke S; van Groen T; Kadish I; Bartnik D; Nagel-Steger L; Brener O; Sehl T; Batra-Safferling R; Moriscot C; Schoehn G; Horn AH; Müller-Schiffmann A; Korth C; Sticht H; Willbold D
ACS Chem Neurosci; 2010 Sep; 1(9):639-48. PubMed ID: 22778851
[TBL] [Abstract][Full Text] [Related]
23. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
[TBL] [Abstract][Full Text] [Related]
24. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
25. Surprisingly high stability of the Aβ oligomer eliminating all-d-enantiomeric peptide D3 in media simulating the route of orally administered drugs.
Elfgen A; Santiago-Schübel B; Gremer L; Kutzsche J; Willbold D
Eur J Pharm Sci; 2017 Sep; 107():203-207. PubMed ID: 28711713
[TBL] [Abstract][Full Text] [Related]
26. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.
Kawarabayashi T; Shoji M; Younkin LH; Wen-Lang L; Dickson DW; Murakami T; Matsubara E; Abe K; Ashe KH; Younkin SG
J Neurosci; 2004 Apr; 24(15):3801-9. PubMed ID: 15084661
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of an UHPLC-ESI-QTOF-MS method for quantification of the highly hydrophilic amyloid-β oligomer eliminating all-D-enantiomeric peptide RD2 in mouse plasma.
Hupert M; Elfgen A; Schartmann E; Schemmert S; Buscher B; Kutzsche J; Willbold D; Santiago-Schübel B
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():123-129. PubMed ID: 29248770
[TBL] [Abstract][Full Text] [Related]
28. Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model.
Castillo-Carranza DL; Guerrero-Muñoz MJ; Sengupta U; Hernandez C; Barrett AD; Dineley K; Kayed R
J Neurosci; 2015 Mar; 35(12):4857-68. PubMed ID: 25810517
[TBL] [Abstract][Full Text] [Related]
29. Pyroglutamate-Aβ: role in the natural history of Alzheimer's disease.
Gunn AP; Masters CL; Cherny RA
Int J Biochem Cell Biol; 2010 Dec; 42(12):1915-8. PubMed ID: 20833262
[TBL] [Abstract][Full Text] [Related]
30. Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain.
Perez-Garmendia R; Hernandez-Zimbron LF; Morales MA; Luna-Muñoz J; Mena R; Nava-Catorce M; Acero G; Vasilevko V; Viramontes-Pintos A; Cribbs DH; Gevorkian G
J Alzheimers Dis; 2014; 39(2):441-55. PubMed ID: 24240639
[TBL] [Abstract][Full Text] [Related]
31. In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer's Disease.
Schartmann E; Schemmert S; Niemietz N; Honold D; Ziehm T; Tusche M; Elfgen A; Gering I; Brener O; Shah NJ; Langen KJ; Kutzsche J; Willbold D; Willuweit A
J Alzheimers Dis; 2018; 64(3):859-873. PubMed ID: 29966196
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's disease as oligomeropathy.
Ono K
Neurochem Int; 2018 Oct; 119():57-70. PubMed ID: 28821400
[TBL] [Abstract][Full Text] [Related]
33. Low-n oligomers as therapeutic targets of Alzheimer's disease.
Ono K; Yamada M
J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
[TBL] [Abstract][Full Text] [Related]
34. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
[TBL] [Abstract][Full Text] [Related]
35. Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer's disease.
Zhao M; Wang SW; Wang YJ; Zhang R; Li YN; Su YJ; Zhou WW; Yu XL; Liu RT
Curr Alzheimer Res; 2014 Jan; 11(1):69-78. PubMed ID: 24156260
[TBL] [Abstract][Full Text] [Related]
36. Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.
Cerpa W; Dinamarca MC; Inestrosa NC
Curr Alzheimer Res; 2008 Jun; 5(3):233-43. PubMed ID: 18537540
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
38. In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches.
Balducci C; Forloni G
Curr Pharm Des; 2014; 20(15):2491-505. PubMed ID: 23859553
[TBL] [Abstract][Full Text] [Related]
39. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
40. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
